Prokidney Corp (PROK) Stock Price, Quote & News

Company Profile

ProKidney Corp., a clinical-stage biotechnology company, develops a cell therapy platform for the treatment of multiple chronic kidney diseases in the United States. Its lead product candidate, rilparencel, includes autologous selected renal cells (SRC) in Phase 3 and Phase 2 clinical studies in subjects with moderate to severe chronic kidney disease and diabetes. The company also develops a cryopreserved version of rilparencel that allows for long-term product preservation to be used in Phase 2...

Industry: Biotechnology

Sector: Healthcare

Phone: 336 999 7028

Website: prokidney.com

Address:

2000 Frontis Plaza Blvd., Suite 250, Winston-Salem, United States

wavridr Oct. 24 at 7:40 PM

$PROK Nasdaq +303, this POS -2 cents 🤣🤣🤣

0 · Reply

wavridr Oct. 24 at 7:06 PM

$PROK Nasdaq +300. This POS +1 penny 😂😂

0 · Reply

Doozio Oct. 24 at 4:26 PM

$PROK MOAR then FOUR during 🐒🍌🧠⏰♾️

0 · Reply

uniquelook Oct. 24 at 3:48 PM

$PROK Four is in the view 🚀🚀🚀🚀

0 · Reply

M47774M Oct. 24 at 1:54 PM

$PROK I’m in

0 · Reply

wavridr Oct. 23 at 3:38 PM

$PROK broke yesterday's low by 2 cents 😂 just a little more to close below 3 🔨🔨🔨

0 · Reply

wavridr Oct. 23 at 2:41 PM

$PROK how many times has the been red when everything is green? A true POS 😂

0 · Reply

uniquelook Oct. 23 at 2:12 PM

$PROK Could move on a sneeze Clinical trial results next month 🚀🚀

0 · Reply

ProfessorGamma Oct. 23 at 12:32 AM

How much volume do you think it takes to Gap BBGI up? BBGI has not even 700k shares float and recent news. Hoping for a 100% run on BBGI $TNYA $RGC $NVFY $PROK Watchlist>

0 · Reply

wavridr Oct. 22 at 3:44 PM

$PROK looking good.. close below 3 🔨🔨🔨

0 · Reply

ProKidney Announces Two Abstracts Selected for Presentation at the American Society of Nephrology's Kidney Week 2025

Sep 19, 2025, 10:52 AM EDT - 5 weeks ago

ProKidney: Slow-Burning 'Buy' Opportunity Based On 2027 Approval Of Kidney Disease Therapy

Sep 8, 2025, 10:14 AM EDT - 6 weeks ago

ProKidney Corp. (PROK) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Sep 3, 2025, 2:08 PM EDT - 7 weeks ago

ProKidney Corp. (PROK) Presents At Citi's Biopharma Back To School Conference Transcript

Aug 27, 2025, 7:30 AM EDT - 2 months ago

ProKidney to Participate in Two Upcoming Conferences: the Citi Biopharma Back to School Conference and the Morgan Stanley Global Healthcare Conference

Aug 12, 2025, 4:01 PM EDT - 2 months ago

ProKidney Reports Second Quarter 2025 Financial Results and Provides Regulatory and Clinical Updates

Jul 15, 2025, 7:30 AM EDT - 3 months ago

ProKidney Announces Alignment with the FDA on the Accelerated Approval Pathway for Rilparencel

Jul 9, 2025, 11:22 AM EDT - 3 months ago

Trump's latest tariff threats and the impact on markets, ProKidney stock jumps over 500%

Jul 9, 2025, 8:45 AM EDT - 3 months ago

ProKidney: What's Happening With PROK Stock?

Jul 9, 2025, 7:30 AM EDT - 3 months ago

ProKidney to Participate in the H.C. Wainwright 4th Annual Kidney Virtual Conference

Jul 8, 2025, 5:09 PM EDT - 3 months ago

ProKidney's stock rockets on ‘intriguing' news, but analyst doesn't recommend buying

Jul 8, 2025, 1:25 PM EDT - 3 months ago

Gold Falls 1%; ProKidney Shares Spike Higher

Jul 8, 2025, 9:05 AM EDT - 3 months ago

Why Is Penny Stock ProKidney Trading Higher On Tuesday?

Jul 8, 2025, 7:00 AM EDT - 3 months ago

ProKidney Reports Statistically and Clinically Significant Topline Results for the Phase 2 REGEN-007 Trial Evaluating Rilparencel in Patients with Chronic Kidney Disease and Diabetes

Jul 1, 2025, 12:43 PM EDT - 4 months ago

ProKidney Corp. Completes Domestication from the Cayman Islands to Delaware

May 12, 2025, 4:15 PM EDT - 5 months ago

ProKidney Reports First Quarter 2025 Financial Results and Business Highlights

Mar 17, 2025, 7:30 AM EDT - 7 months ago

ProKidney Reports Full Year 2024 Financial Results and Business Highlights

Jan 31, 2025, 11:08 AM EST - 9 months ago

Kuehn Law Encourages Investors of ProKidney Corp. to Contact Law Firm

Jan 31, 2025, 6:10 AM EST - 9 months ago

2025 Will Be A Major Year For ProKidney's Rilparencel In CKD Treatment

Nov 26, 2024, 7:30 AM EST - 11 months ago

ProKidney to Participate in Two Upcoming Conferences: Evercore HealthCONx Conference and the Citi Global Healthcare Conference

Nov 12, 2024, 7:30 AM EST - 1 year ago

ProKidney Reports Third Quarter 2024 Financial Results along with Regulatory and Clinical Development Updates Following Successful FDA Type B Meeting

Nov 5, 2024, 7:30 AM EST - 1 year ago

ProKidney to Participate in the Guggenheim Inaugural Healthcare Innovation Conference and the Jefferies London Healthcare Conference

Oct 14, 2024, 7:30 AM EDT - 1 year ago

ProKidney Announces Five Abstracts Selected for Presentation at the American Society of Nephrology's Kidney Week 2024

Oct 9, 2024, 7:30 AM EDT - 1 year ago

ProKidney to Participate in the UBS Virtual Organ Restoration Day

Sep 3, 2024, 7:30 AM EDT - 1 year ago

ProKidney Announces Strategic Updates to its Phase 3 Program to Accelerate Rilparencel's Registrational Path to Potential Approval in the U.S.

Aug 27, 2024, 7:30 AM EDT - 1 year ago

ProKidney to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference

Aug 9, 2024, 7:00 AM EDT - 1 year ago

ProKidney Reports Business Updates and Second Quarter 2024 Financial Results

Jun 11, 2024, 9:35 PM EDT - 1 year ago

ProKidney Announces Pricing of its Upsized $130 Million Public Offering of Class A Ordinary Shares and Concurrent Registered Direct Offering

Jun 10, 2024, 4:15 PM EDT - 1 year ago

ProKidney Announces Proposed $125 Million Public Offering of Class A Ordinary Shares and Concurrent Registered Direct Offering

Jun 10, 2024, 6:30 AM EDT - 1 year ago

ProKidney Announces Positive Interim REGEN-007 Phase 2 Trial Data and Provides Clinical and Operational Updates

May 29, 2024, 7:00 AM EDT - 1 year ago

ProKidney to Participate in the Jefferies Global Healthcare Conference

May 21, 2024, 7:00 AM EDT - 1 year ago

ProKidney to Host Virtual KOL Event to Discuss Current Treatment Landscape of Chronic Kidney Disease Caused by Diabetes and Data from Phase 2 RMCL-002 Clinical Trial on May 28, 2024

May 10, 2024, 7:00 AM EDT - 1 year ago

ProKidney Reports Business Updates and First Quarter 2024 Financial Results

Mar 25, 2024, 6:05 AM EDT - 1 year ago

ProKidney Announces Key Leadership Appointments Strengthening Clinical and Technical Operations

Mar 21, 2024, 7:49 PM EDT - 1 year ago

ProKidney Reports Full Year 2023 Financial Results and Recent Corporate Highlights

Feb 29, 2024, 4:05 PM EST - 1 year ago

ProKidney to Participate in Jefferies Biotech on the Bay Summit

Nov 30, 2023, 6:05 AM EST - 2 years ago

ProKidney Appoints Nikhil Pereira-Kamath, MBA, as Chief Business Officer

Nov 21, 2023, 6:05 AM EST - 2 years ago

ProKidney to Participate in a Fireside Chat at the Upcoming Evercore ISI 6th Annual HEALTHCONx Conference

Nov 16, 2023, 4:40 PM EST - 2 years ago

ProKidney Corp. (PROK) Q3 2023 Earnings Call Transcript

Nov 14, 2023, 6:05 AM EST - 2 years ago

ProKidney Reports Third Quarter Financial Results

Nov 13, 2023, 5:02 PM EST - 2 years ago

ProKidney Announces Positive Interim Data from RMCL-002 Phase 2 Clinical Trial of Renal Autologous Cell Therapy (REACT®) for Diabetic CKD and Provides Corporate Updates

Oct 30, 2023, 4:12 PM EDT - 2 years ago

ProKidney Announces Four Abstracts Selected for Presentation at the American Society of Nephrology's Kidney Week 2023

Sep 5, 2023, 6:05 AM EDT - 2 years ago

ProKidney to Participate in Fireside Chat at the Morgan Stanley Global Healthcare Conference

Aug 10, 2023, 4:10 PM EDT - 2 years ago

ProKidney Reports Second Quarter Financial Results and Recent Corporate Highlights

Jul 18, 2023, 6:05 AM EDT - 2 years ago

ProKidney Announces Closing of Purchase of Manufacturing Facility in Greensboro, NC

Jul 15, 2023, 2:02 AM EDT - 2 years ago

ProKidney Appoints Bruce Culleton, MD, as Executive Vice President, Clinical Development and Commercialization

Jun 13, 2023, 12:05 PM EDT - 2 years ago

ProKidney Announces Purchase of Manufacturing Facility in Greensboro, NC

Jun 1, 2023, 4:05 PM EDT - 2 years ago

ProKidney to Participate in Fireside Chat at the Jefferies Healthcare Conference

May 11, 2023, 4:01 PM EDT - 2 years ago

ProKidney Reports First Quarter Financial Results and Recent Corporate Highlights

May 4, 2023, 6:05 AM EDT - 2 years ago

ProKidney to Present at the BofA Securities Health Care Conference 2023

wavridr Oct. 24 at 7:40 PM

$PROK Nasdaq +303, this POS -2 cents 🤣🤣🤣

0 · Reply

wavridr Oct. 24 at 7:06 PM

$PROK Nasdaq +300. This POS +1 penny 😂😂

0 · Reply

Doozio Oct. 24 at 4:26 PM

$PROK MOAR then FOUR during 🐒🍌🧠⏰♾️

0 · Reply

uniquelook Oct. 24 at 3:48 PM

$PROK Four is in the view 🚀🚀🚀🚀

0 · Reply

M47774M Oct. 24 at 1:54 PM

$PROK I’m in

0 · Reply

wavridr Oct. 23 at 3:38 PM

$PROK broke yesterday's low by 2 cents 😂 just a little more to close below 3 🔨🔨🔨

0 · Reply

wavridr Oct. 23 at 2:41 PM

$PROK how many times has the been red when everything is green? A true POS 😂

0 · Reply

uniquelook Oct. 23 at 2:12 PM

$PROK Could move on a sneeze Clinical trial results next month 🚀🚀

0 · Reply

ProfessorGamma Oct. 23 at 12:32 AM

How much volume do you think it takes to Gap BBGI up? BBGI has not even 700k shares float and recent news. Hoping for a 100% run on BBGI $TNYA $RGC $NVFY $PROK Watchlist>

0 · Reply

wavridr Oct. 22 at 3:44 PM

$PROK looking good.. close below 3 🔨🔨🔨

0 · Reply

Strizzball Oct. 22 at 12:38 PM

$PROK patent assigned!

0 · Reply

uniquelook Oct. 21 at 1:07 PM

$PROK WHO KNOWS ?? When more investors want to buy a stock than sell it, its price goes up. 🚀🚀

0 · Reply

scalperofpennystocks Oct. 21 at 11:47 AM

$BURU $BYND not exactly how it works mate. Just because a stock does well dosent mean another one will. Look at $PROK thay ran like crazy then I’ve seen other stocks with similar good phase 2 results run no where near as much so. Your thesis is crap.

0 · Reply

vjtweet Oct. 21 at 4:04 AM

$PROK Still holding full position plus added more today.

0 · Reply

lasoto3 Oct. 20 at 6:55 PM

$PROK okkkkk

0 · Reply

Notar Oct. 20 at 5:49 PM

$PROK

0 · Reply

Thestocktraderhubzee Oct. 20 at 11:48 AM

$PROK ProKidney To Present LAte-Breaking Poster On Phase 2 REGEN-007 Trial Results At American Society of Nephrology's Kidney Week

1 · Reply

uniquelook Oct. 17 at 4:22 PM

$PROK Don’t forget future options TODAY is option expiration day!! Bullish

0 · Reply

wavridr Oct. 17 at 2:58 PM

$PROK chart is a perfect straight line. Don't mess it up 😂 could drop to 2.80 today 📉

0 · Reply

wavridr Oct. 17 at 2:23 PM

$PROK close below 2.90 today 🔨🔨🔨

0 · Reply

uniquelook Oct. 17 at 2:16 PM

$PROK Options expiration today

0 · Reply

uniquelook Oct. 17 at 2:14 PM

$PROK Oversold could bounce anytime a huge percentage ???? 🚀🚀🚀

0 · Reply

Market Cap	938.76M
Revenue (ttm)	80,000.00
Net Income (ttm)	-61.19M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-76,487.50%
Debt to Equity Ratio	0.00

Volume	649,500
Avg Vol	2,104,596
Day's Range	N/A - N/A
Shares Out	294.28M
Stochastic %K	57%
Beta	1.72
Analysts	Sell
Price Target	$5.40